Literature DB >> 2145444

Adenovirus E1A and E1B genes are regulated posttranscriptionally in human lymphoid cells.

D J Lavery1, S Chen-Kiang.   

Abstract

The interactions of adenovirus with differentiated human cells have been investigated in human myeloma cells. Relative to HeLa cells, the E1A and E1B genes, but not other viral genes, were markedly repressed by differential RNA stabilization, resulting in 20- to 50-fold less E1A and E1B mRNAs at steady state late in infection. The reduced E1A level corresponded to an approximately 200-fold-lower abundance of E1A polypeptides, which were nonetheless capable of efficient transactivation of E1A-dependent viral genes and were necessary for productive infection. The E1B gene was further regulated posttranscriptionally, yielding altered molar representation of alternatively spliced 22S and 13S mRNAs early in infection of myeloma cells. Taken together, these results suggested that repression and altered expression of E1A and E1B genes may provide a molecular basis of delayed kinetics of infection of lymphoid cells with adenovirus (D. Lavery, S. M. Fu, T. Lufkin, and S. Chen-Kiang, J. Virol. 61:1466-1472, 1987). The molecular mechanisms by which E1A and E1B are regulated and by which E1A transactivates viral genes in lymphoid cells are discussed.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2145444      PMCID: PMC248584     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  42 in total

1.  Cell-type-specific synthesis of murine immunoglobulin mu RNA from an adenovirus vector.

Authors:  J E Ruether; A Maderious; D Lavery; J Logan; S M Fu; S Chen-Kiang
Journal:  Mol Cell Biol       Date:  1986-01       Impact factor: 4.272

2.  An adenovirus early region 4 gene product is required for induction of the infection-specific form of cellular E2F activity.

Authors:  S Hardy; D A Engel; T Shenk
Journal:  Genes Dev       Date:  1989-07       Impact factor: 11.361

3.  The adenovirus type 5 E1A enhancer contains two functionally distinct domains: one is specific for E1A and the other modulates all early units in cis.

Authors:  P Hearing; T Shenk
Journal:  Cell       Date:  1986-04-25       Impact factor: 41.582

4.  Deletion mutants that alter differential RNA processing in the E3 complex transcription unit of adenovirus.

Authors:  B M Bhat; H A Brady; M H Pursley; W S Wold
Journal:  J Mol Biol       Date:  1986-08-20       Impact factor: 5.469

5.  Differential stability of c-myc mRNAS in a cell-free system.

Authors:  R Pei; K Calame
Journal:  Mol Cell Biol       Date:  1988-07       Impact factor: 4.272

6.  Autogenous regulation of histone mRNA decay by histone proteins in a cell-free system.

Authors:  S W Peltz; J Ross
Journal:  Mol Cell Biol       Date:  1987-12       Impact factor: 4.272

7.  cAMP acts in synergy with E1A protein to activate transcription of the adenovirus early genes E4 and E1A.

Authors:  D A Engel; S Hardy; T Shenk
Journal:  Genes Dev       Date:  1988-12       Impact factor: 11.361

8.  Identification of an AUUUA-specific messenger RNA binding protein.

Authors:  J S Malter
Journal:  Science       Date:  1989-11-03       Impact factor: 47.728

9.  Concentration dependence of transcriptional transactivation in inducible E1A-containing human cells.

Authors:  L J Brunet; A J Berk
Journal:  Mol Cell Biol       Date:  1988-11       Impact factor: 4.272

10.  Poly(A) shortening and degradation of the 3' A+U-rich sequences of human c-myc mRNA in a cell-free system.

Authors:  G Brewer; J Ross
Journal:  Mol Cell Biol       Date:  1988-04       Impact factor: 4.272

View more
  8 in total

1.  Adenovirus E3-6.7K maintains calcium homeostasis and prevents apoptosis and arachidonic acid release.

Authors:  Alexander R Moise; Jason R Grant; Timothy Z Vitalis; Wilfred A Jefferies
Journal:  J Virol       Date:  2002-02       Impact factor: 5.103

2.  E1A 12S and 13S of the transformation-defective adenovirus type 12 strain CS-1 inactivate proteins of the RB family, permitting transactivation of the E2F-dependent promoter.

Authors:  B M Pützer; H Rumpf; S Rega; D Brockmann; H Esche
Journal:  J Virol       Date:  1997-12       Impact factor: 5.103

3.  Down-regulation of HLA antigens by the adenovirus type 2 E3/19K protein in a T-lymphoma cell line.

Authors:  H Körner; H G Burgert
Journal:  J Virol       Date:  1994-03       Impact factor: 5.103

4.  Infection and killing of multiple myeloma by adenoviruses.

Authors:  Julien S Senac; Konstantin Doronin; Stephen J Russell; Diane F Jelinek; Philip R Greipp; Michael A Barry
Journal:  Hum Gene Ther       Date:  2010-02       Impact factor: 5.695

5.  Convergent regulation of NF-IL6 and Oct-1 synthesis by interleukin-6 and retinoic acid signaling in embryonal carcinoma cells.

Authors:  W Hsu; S Chen-Kiang
Journal:  Mol Cell Biol       Date:  1993-04       Impact factor: 4.272

6.  Dissecting the roles of E1A and E1B in adenoviral replication and RCAd-enhanced RDAd transduction efficacy on tumor cells.

Authors:  Fang Wei; Huiping Wang; Xiafang Chen; Chuanyuan Li; Qian Huang
Journal:  Cancer Biol Ther       Date:  2014-07-14       Impact factor: 4.742

7.  NF-IL6, a member of the C/EBP family, regulates E1A-responsive promoters in the absence of E1A.

Authors:  J M Spergel; W Hsu; S Akira; B Thimmappaya; T Kishimoto; S Chen-Kiang
Journal:  J Virol       Date:  1992-02       Impact factor: 5.103

8.  Interleukin 6 enhances a cellular activity that functionally substitutes for E1A protein in transactivation.

Authors:  J M Spergel; S Chen-Kiang
Journal:  Proc Natl Acad Sci U S A       Date:  1991-08-01       Impact factor: 11.205

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.